Market Overview:
The global wound and skin infection treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of wound and skin infections, rising demand for advanced wound care products, and growing awareness about advanced wound care treatments. The global wound and skin infection treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into traditional treatment, basic treatment, bio-active treatment, and advanced treatment. On the basis of application, the market is segmented into biotechnology companies, pharmaceutical companies hospital laboratory and diagnostic laboratory academic research institutes others).
Product Definition:
A wound is a break in the skin. A skin infection is an infection of the skin. Treatment for a wound or a skin infection may include antibiotics, surgery, and/or dressings. Treatment for wounds and infections is important because they can cause pain, disability, and even death if not treated properly.
Traditional Treatment:
Traditional treatment includes the use of antimicrobial agents such as silver and iodine. The growth factor in wound and skin infection treatment market is referred to as traditional or conventional treatment.
Factors responsible for the growth of this segment include rising awareness among patients, demand for minimally invasive procedures, technological advancements in products used such as iodine based antiseptics, creams & lotions etc., increasing prevalence of chronic diseases leading to rise in hospital admissions etc.
Basic Treatment:
Basic treatment and it's usage in wound and skin infection treatment market is a new emerging trend in the healthcare industry. The basic treatment for wound infection includes debridement (removal of dead tissue), irrigation, dressing change, antibiotics if required, and elevation. Skin infections are caused due to bacterial or fungal pathogens that enter the body through breaks in the skin such as abrasions, burns or lacerations.
Application Insights:
The academic and research institutes segment held the largest share of the global wound and skin infection treatment market in 2017. This is due to rising number of researchers working on various aspects related to wound healing process. For instance, according to a study published by National Center for Biotechnology Information (NCBI) in 2018, it was found that vitamin C deficiency accelerates the rate of tissue repair during burn injury. Therefore, increasing focus on burns as a major cause of mortality worldwide is expected to boost demand for advanced wound care products over the forecast period.
On other hand, pharmaceutical companies are focusing more on chronic wounds as they are associated with high risk factors such as diabetes and obesity which may lead to further complications including ulcers and infections if proper treatment is not taken immediately after initial diagnosis by a healthcare professional.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as increasing cases of chronic wounds, rising geriatric population, and high adoption of advanced treatment options. Moreover, presence of key players in this region is expected to boost revenue generation from this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increase government initiatives for wound care products development coupled with growing medical tourism industry supported by low cost treatment options offered by countries such as India and China.
Growth Factors:
- Increasing incidence of wound and skin infection
- Rising demand for advanced wound care products
- Growing awareness about wound and skin infection treatment options
- Proliferation of private clinics and hospitals offering wound care services
- Technological advancements in wound care products
Scope Of The Report
Report Attributes
Report Details
Report Title
Wound and Skin Infection Treatment Market Research Report
By Type
Traditional Treatment, Basic Treatment, Bio-Active Treatment, Advanced Treatment
By Application
Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes, Others
By Companies
3M, Coloplast, B. Braun Melsungen, Smith & Nephew, Genzyme, ConvaTec Healthcare, Human BioSciences, MediPurpose, Medtronic, J&J Medical, Acelity, Carinal Health, Medline, Integra LifeSciences, MiMedx Group, Mölnlycke
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Wound and Skin Infection Treatment Market Report Segments:
The global Wound and Skin Infection Treatment market is segmented on the basis of:
Types
Traditional Treatment, Basic Treatment, Bio-Active Treatment, Advanced Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Coloplast
- B. Braun Melsungen
- Smith & Nephew
- Genzyme
- ConvaTec Healthcare
- Human BioSciences
- MediPurpose
- Medtronic
- J&J Medical
- Acelity
- Carinal Health
- Medline
- Integra LifeSciences
- MiMedx Group
- Mölnlycke
Highlights of The Wound and Skin Infection Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Traditional Treatment
- Basic Treatment
- Bio-Active Treatment
- Advanced Treatment
- By Application:
- Biotechnology Companies
- Pharmaceutical Companies
- Hospital Laboratory and Diagnostic Laboratory
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wound and Skin Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wound and skin infection treatment is the process of treating a wound or skin infection. Treatment may include antibiotics, pain relief, and cleaning.
Some of the key players operating in the wound and skin infection treatment market are 3M, Coloplast, B. Braun Melsungen, Smith & Nephew, Genzyme, ConvaTec Healthcare, Human BioSciences, MediPurpose, Medtronic, J&J Medical, Acelity, Carinal Health, Medline, Integra LifeSciences, MiMedx Group, MƒÂ¶lnlycke.
The wound and skin infection treatment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Wound and Skin Infection Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Wound and Skin Infection Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Wound and Skin Infection Treatment Market - Supply Chain
4.5. Global Wound and Skin Infection Treatment Market Forecast
4.5.1. Wound and Skin Infection Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Wound and Skin Infection Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Wound and Skin Infection Treatment Market Absolute $ Opportunity
5. Global Wound and Skin Infection Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
5.3.1. Traditional Treatment
5.3.2. Basic Treatment
5.3.3. Bio-Active Treatment
5.3.4. Advanced Treatment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Wound and Skin Infection Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
6.3.1. Biotechnology Companies
6.3.2. Pharmaceutical Companies
6.3.3. Hospital Laboratory and Diagnostic Laboratory
6.3.4. Academic and Research Institutes
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Wound and Skin Infection Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Wound and Skin Infection Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Wound and Skin Infection Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Wound and Skin Infection Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Wound and Skin Infection Treatment Demand Share Forecast, 2019-2026
9. North America Wound and Skin Infection Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Wound and Skin Infection Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
9.4.1. Biotechnology Companies
9.4.2. Pharmaceutical Companies
9.4.3. Hospital Laboratory and Diagnostic Laboratory
9.4.4. Academic and Research Institutes
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
9.7.1. Traditional Treatment
9.7.2. Basic Treatment
9.7.3. Bio-Active Treatment
9.7.4. Advanced Treatment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Wound and Skin Infection Treatment Demand Share Forecast, 2019-2026
10. Latin America Wound and Skin Infection Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Wound and Skin Infection Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
10.4.1. Biotechnology Companies
10.4.2. Pharmaceutical Companies
10.4.3. Hospital Laboratory and Diagnostic Laboratory
10.4.4. Academic and Research Institutes
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
10.7.1. Traditional Treatment
10.7.2. Basic Treatment
10.7.3. Bio-Active Treatment
10.7.4. Advanced Treatment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Wound and Skin Infection Treatment Demand Share Forecast, 2019-2026
11. Europe Wound and Skin Infection Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Wound and Skin Infection Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
11.4.1. Biotechnology Companies
11.4.2. Pharmaceutical Companies
11.4.3. Hospital Laboratory and Diagnostic Laboratory
11.4.4. Academic and Research Institutes
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
11.7.1. Traditional Treatment
11.7.2. Basic Treatment
11.7.3. Bio-Active Treatment
11.7.4. Advanced Treatment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Wound and Skin Infection Treatment Demand Share, 2019-2026
12. Asia Pacific Wound and Skin Infection Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Wound and Skin Infection Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
12.4.1. Biotechnology Companies
12.4.2. Pharmaceutical Companies
12.4.3. Hospital Laboratory and Diagnostic Laboratory
12.4.4. Academic and Research Institutes
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
12.7.1. Traditional Treatment
12.7.2. Basic Treatment
12.7.3. Bio-Active Treatment
12.7.4. Advanced Treatment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Wound and Skin Infection Treatment Demand Share, 2019-2026
13. Middle East & Africa Wound and Skin Infection Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Wound and Skin Infection Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Wound and Skin Infection Treatment Market Size and Volume Forecast by Application
13.4.1. Biotechnology Companies
13.4.2. Pharmaceutical Companies
13.4.3. Hospital Laboratory and Diagnostic Laboratory
13.4.4. Academic and Research Institutes
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Wound and Skin Infection Treatment Market Size and Volume Forecast by Type
13.7.1. Traditional Treatment
13.7.2. Basic Treatment
13.7.3. Bio-Active Treatment
13.7.4. Advanced Treatment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Wound and Skin Infection Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Wound and Skin Infection Treatment Market: Market Share Analysis
14.2. Wound and Skin Infection Treatment Distributors and Customers
14.3. Wound and Skin Infection Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Coloplast
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun Melsungen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Smith & Nephew
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Genzyme
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ConvaTec Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Human BioSciences
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. MediPurpose
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. J&J Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Acelity
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Carinal Health
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Medline
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Integra LifeSciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. MiMedx Group
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Mölnlycke
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
